| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.18 | 8e-05 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0001 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |